Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

Download to gain expert insights and data-driven analysis from the ASCO 2025 Annual Meeting. This report covers key ...

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

Pāpāmoa retiree Marion Henriksen was meant to be travelling in Germany and Austria with a friend. Instead, she had to cancel ...

Market report includes a comprehensive understanding of current treatment practices, emerging HER2+ gastric cancer therapies, market share of individual therapies, and current and forecasted HER2+ ...

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Job opportunities at the Port of Los Angeles are dwindling as President Trump's steep tariffs take a hit on global trade and a major economic engine for the regional economy.

Kim Novak, the glamorous and fiercely independent star of Alfred Hitchcock’s “Vertigo,” will be honored with a lifetime ...

Just in time for peak travel season, Terminix®, a Rentokil Terminix company, announced today its annual list of the Top 50 Most Bed Bug-Infested U.S. Cities, based on 2024 service data from more than ...

Carey International, a renowned global provider of premium chauffeured services and ground transportation solutions and a portfolio company of The Najafi Companies, announced the appointment of ...

The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...